Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA binding motif protein 47 (RBM47) is a multifunctional RNA-binding protein primarily located in the cytoplasm and nucleus. RBM47 binds single-stranded RNA and is involved in processes such as alternative splicing, RNA stabilization, and cytidine to uridine editing, acting as an enzyme-substrate adaptor especially for the cytidine deaminase APOBEC1. It forms mRNA editing complexes, stabilizes various mRNAs via binding at introns and 3′UTRs, and regulates genes including the interferon alpha/beta receptor and interleukin-10. RBM47 serves as a tumor suppressor: its loss is linked to breast cancer metastasis and poor prognosis in clear cell renal carcinoma. It also modulates epithelial-mesenchymal transition, interferon response, and RNA stability in cancer cells. Although it has no direct tumor suppressive signaling function, the widespread modulation of RNA biogenesis—including splicing and stability—by RBM47 can alter phenotypes critical to cancer progression[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA binding motif protein 47 (RBM47).